Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring

被引:0
|
作者
Maria de los Milagros Bassani Molinas
Christiane Beer
Friedemann Hesse
Manfred Wirth
Roland Wagner
机构
[1] UOCCB-ANLIS “Dr. Carlos G Malbrán”,Institute for Molecular Biology
[2] Aarhus University,Cell Culture Technology
[3] Biberach University of Applied Sciences,Epigenetic Regulation
[4] Helmholtz Centre for Infection Research,Bioprocess Development
[5] Rentschler Biotechnologie GmbH,undefined
来源
Cytotechnology | 2014年 / 66卷
关键词
Mammalian biotechnology; Cell culture; Gene expression; Transient transfection;
D O I
暂无
中图分类号
学科分类号
摘要
Large scale, transient gene expression (TGE) is highly dependent of the physiological status of a cell line. Therefore, intracellular nucleotide pools and ratios were used for identifying and monitoring the optimal status of a suspension cell line used for TGE. The transfection efficiency upon polyethyleneimine (PEI)-mediated transient gene delivery into HEK-293 cells cultured in suspension was investigated to understand the effect of different culture and transfection conditions as well as the significance of the culture age and the quality of the cell line used. Based on two different bicistronic model plasmids expressing the human erythropoietin gene (rHuEPO) in the first position and green fluorescent protein as reporter gene in the second position and vice versa, a completely serum-free transient transfection process was established. The process makes use of a 1:1 mixture of a special calcium-free DMEM and the FreeStyle™ 293 Expression Medium. Maximum transfectability was achieved by adjusting the ratio for complex formation to one mass part of DNA and three parts of PEI corresponding to an N/P (nitrogen residues/DNA phosphates) ratio of 23 representing a minimum amount of DNA for the polycation-mediated gene delivery. Applying this method, maximum transfectabilities between 70 and 96 % and a rHuEPO concentration of 1.6 μg mL−1 72 h post transfection were reached, when rHuEPO gene was expressed from the first position of the bicistronic mRNA. This corresponded to 10 % of the total protein concentration in the cell-free supernatant of the cultures in protein-free medium. Up to 30 % higher transfectabilities were found for cells of early passages compared to those from late passages under protein-free culture conditions. In contrast, when the same cells were propagated in serum-containing medium, higher transfectabilities were found for late-passage cells, while up to 40 % lower transfectabilities were observed for early-passage cells. Nucleotide pools were measured during all cell cultivations and the nucleoside triphosphate/uridine ratios were calculated. These ‘nucleotide ratios’ changed in an age-dependent manner and could be used to distinguish early- from late-passage cells. The observed effects were also dependent on the presence of serum in the culture. Nucleotide ratios were shown being applied to investigate the optimal passage number of cultured cell lines for achieving a maximum productivity in cultures used for transient gene expression. Furthermore, these nucleotide ratios proved to be different for transfected and untransfected cells, providing a high potential tool to monitor the status of transfection under various culture conditions.
引用
收藏
页码:493 / 514
页数:21
相关论文
共 50 条
  • [21] Establishment of a Robust Serum Free Suspension HEK293 Transient Transfection Platform for Recombinant AAV Production
    Nie, Yingchao
    Sokolowski, Mark
    Chen, Kevin
    Renzi, Christopher
    Figueroa, Bruno
    Vincent, Karen
    MOLECULAR THERAPY, 2022, 30 (04) : 536 - 536
  • [22] Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells
    Chung, Cheng-Han
    Murphy, Christopher M.
    Wingate, Vincent P.
    Pavlicek, Jeffrey W.
    Nakashima, Reiko
    Wei, Wei
    Mccarty, Douglas
    Rabinowitz, Joseph
    Barton, Erik
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 28 : 272 - 283
  • [23] Development of a scalable viral vector upstream process for gene therapy: rAAV-8 production by transfection of HEK-293 cells in iCELLis™ bioreactor
    Reniers, R. Andy
    Van Huffel, V. Christophe
    Merten, M. Otto-Wilhelm
    Hebben, H. Matthias
    Rousseau, R. Cedrick
    Arias, A. Simon
    Hohoud, H. Moustapha
    Lievrouw, L. Roel
    Moncaubeig, M. Fabien
    Nowicki, N. Paule
    Cancian, C. Catherine
    HUMAN GENE THERAPY, 2016, 27 (11) : A88 - A88
  • [24] Enhanced glycoprotein production in HEK-293 cells expressing pyruvate carboxylase
    Henry, Olivier
    Durocher, Yves
    METABOLIC ENGINEERING, 2011, 13 (05) : 499 - 507
  • [25] A Guide to Transient Expression of Membrane Proteins in HEK-293 Cells for Functional Characterization
    Ooi, Amanda
    Wong, Aloysius
    Esau, Luke
    Lemtiri-Chlieh, Fouad
    Gehring, Chris
    FRONTIERS IN PHYSIOLOGY, 2016, 7
  • [26] Enhancing Protein Expression in HEK-293 Cells by Lowering Culture Temperature
    Lin, Chi-Yen
    Huang, Zhen
    Wen, Wei
    Wu, Andrew
    Wang, Congzhou
    Niu, Li
    PLOS ONE, 2015, 10 (04):
  • [27] Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters
    Heng, Zealyn Shi-Lin
    Yeo, Joshua Yi
    Koh, Darius Wen-Shuo
    Gan, Samuel Ken-En
    Ling, Wei-Li
    ANTIBODY THERAPEUTICS, 2022, 5 (01) : 30 - 41
  • [28] Green fluorescent protein as an efficient marker for large-scale process development in stable CHO cells and in transient HEK-293 cells.
    Wurm, FM
    Hunt, L
    Meissner, P
    Girard, P
    Grosjean, F
    Jordan, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U227 - U228
  • [29] Stable transfection of the prostacyclin receptor into HEK-293 cells confers antiproliferative properties to prostacyclin analogues
    Falcetti, E.
    Tinker, A.
    Flavell, D.
    Haworth, S. G.
    Clapp, L. H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 106 - 106
  • [30] Evaluation of a new chemically defined medium for production of AAV vectors by transient transfection of suspension HEK293 cells in stirred tank bioreactors
    Guianvarch, L.
    Boussicault, F.
    Dufour, D.
    Oubaidour, M. A.
    Giambelluco, E.
    Sirantoine, G.
    Hebben, M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A166 - A166